Correlation Between Janux Therapeutics and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Janux Therapeutics and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Syndax Pharmaceuticals.
Diversification Opportunities for Janux Therapeutics and Syndax Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Janux and Syndax is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Syndax Pharmaceuticals
Given the investment horizon of 90 days Janux Therapeutics is expected to generate 0.35 times more return on investment than Syndax Pharmaceuticals. However, Janux Therapeutics is 2.82 times less risky than Syndax Pharmaceuticals. It trades about -0.21 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 5,175 in Janux Therapeutics on August 24, 2024 and sell it today you would lose (525.00) from holding Janux Therapeutics or give up 10.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Janux Therapeutics vs. Syndax Pharmaceuticals
Performance |
Timeline |
Janux Therapeutics |
Syndax Pharmaceuticals |
Janux Therapeutics and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Janux Therapeutics and Syndax Pharmaceuticals
The main advantage of trading using opposite Janux Therapeutics and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute |
Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |